Blackstone: New $1.9bn Potential Sale of Alinamin Explained

Signage is seen at the Blackstone Group headquarters in New York City, U.S. PHOTO: Jeenah Moon/Reuters

Blackstone Inc. is considering selling Alinamin Pharmaceutical Co., a Japanese consumer healthcare firm previously owned by Takeda Pharmaceutical Co., according to individuals familiar with the matter. The world’s largest alternative asset manager, Blackstone, is working with financial advisers on the potential sale of Tokyo-based Alinamin, which could be valued at around ¥300 billion ($1.9 billion). […]